A Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis

Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS

NCT02675413 ·Status: WITHDRAWN ·Phase: PHASE4

To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis

NCT03856619 ·Status: COMPLETED ·Phase: PHASE4

Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States

NCT01873417 ·Status: COMPLETED ·Phase: PHASE4

Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera

NCT02410278 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With Dimethyl Fumarate

NCT02090348 ·Status: WITHDRAWN ·Phase: PHASE4

A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)

NCT07138833 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Dimethyl Fumarate (DMF, Tecfidera®) Persistence in RR-MS Patients Included in the French Patient Support Program OroSEP

NCT04221191 ·Status: COMPLETED

Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

NCT01487096 ·Status: COMPLETED ·Phase: PHASE2

Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MS

NCT02218879 ·Status: TERMINATED

Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera

NCT04756687 ·Status: COMPLETED

Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate

NCT02901106 ·Status: TERMINATED ·Phase: PHASE4

Effects of Dimethyl Fumarate on Cognitive Performance and Brain Abnormalities in Multiple Sclerosis.

NCT05811949 ·Status: COMPLETED

Tecfidera Diffusion Tensor Imaging

NCT02686684 ·Status: COMPLETED

Teriflunomide Tecfidera LMCE

NCT03526224 ·Status: COMPLETED

Dimethyl Fumarate (DMF) Observational Study

NCT02047097 ·Status: COMPLETED

Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece

NCT03101735 ·Status: COMPLETED

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

NCT02823951 ·Status: COMPLETED

Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

NCT00228163 ·Status: COMPLETED ·Phase: PHASE2

Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis

NCT00134563 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)

NCT02907177 ·Status: TERMINATED ·Phase: PHASE3

Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis

NCT01863888 ·Status: COMPLETED ·Phase: PHASE3

Tecfidera Slow-Titration Study

NCT02428231 ·Status: TERMINATED ·Phase: PHASE3

Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.

NCT02097849 ·Status: COMPLETED ·Phase: PHASE2

Tecfidera Lymphocyte Chart Review

NCT02519413 ·Status: COMPLETED

Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study

NCT01006941 ·Status: COMPLETED ·Phase: PHASE2